A-443654 NEW

$2.00 100KG

$4.00 25KG

$5.00 1KG

Min. Order0.1KG
Purity99%
Cas No552325-16-3
Supply Abilityg-kg-tons
Update time2025-10-13

ZHENGZHOU JIUYI TIME NEW MATERIALS CO,.LTD

VIP1Y

China

Chemical Properties

Product Name	A-443654
CAS No	552325-16-3
EC-No
Min. Order	0.1KG
Purity	99%
Supply Ability	g-kg-tons
Release date	2025/10/13

A-443654

Modify Date: 2024-01-02 13:29:25

A-443654 structure	Common Name	A-443654
	CAS Number	552325-16-3	Molecular Weight	397.472
	Density	1.3±0.1 g/cm3	Boiling Point	722.0±60.0 °C at 760 mmHg
	Molecular Formula	C24H23N5O	Melting Point	N/A
	MSDS	N/A	Flash Point	390.4±32.9 °C

Purity		Quantity		Budget		Inquiry

Use of A-443654

A-443654 is a potent Akt1/2/3 inhbitor, with a Ki of 160 pM for Akt1.

Properties
Spectrum

Name	(2S)-1-(1H-indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan-2-amine
Synonym	More Synonyms

Description	A-443654 is a potent Akt1/2/3 inhbitor, with a Ki of 160 pM for Akt1.
Related Catalog	Signaling Pathways >> PI3K/Akt/mTOR >> Akt Research Areas >> Cancer
Target	Akt1:160 pM (Ki) Akt2:160 pM (Ki) Akt3:160 pM (Ki) PKA:6.3 nM (Ki) PKCγ:24 nM (Ki) PKCδ:33 nM (Ki) KDR:3.1 μM (Ki) cKIT:1.2 μM (Ki) SRC:2.6 μM (Ki) Flt1:3.6 μM (Ki) CDK2:24 nM (Ki) ERK2:340 nM (Ki) GSK3β:41 nM (Ki) CK2:2.4 μM (Ki) Chk1:2.3 μM (Ki) RSK2:11 nM (Ki) MAPK-AP2:3.3 μM (Ki)
In Vitro	A-443654 exhibits a Ki of 160 pM, a 30,000-fold improvement in potency versus the initial lead molecule. A-443654 is 40-fold selective for Akt over PKA. A-443654 inhibits Akt1, Akt2, or Akt3 equally within cells. A-443654 reduces the P-GSK3 in a dose-responsive manner in all three cell lines. A-443654 inhibits the proliferation of tumor cells with EC50 of 0.1 μM[1]. A-443654-induced morphological changes occur very rapidly (within 2 to 4 h) in both 10A and 10CA1a cells, with 10CA1a cells more sensitive to A-443654 than the 10A cells. A-443654 alone at 2 μM causes the 10CA1a cells, but not the 10A cells, to detach from the plate after 12 h, whereas 1 μM of A-443654 causes 10CA1a cells to detach from the plate after 12 h. FACScan Analysis of rapamycin and A-443654 effects on DNA content in 10A and 10CA1a cells. In contrast, A-443654 at 2 and 5 μM decreases Bcl-2 levels by 30 to 40% in the 10CA1a cells at 8h. The combination of rapamycin with 2 or 5 μM A-443654, however, markedly decreases Bcl-2 protein levels by appr 40 to 50% in the 10A cells and by appr 70% in the 10CA1a cells, respectively[2]. A-443654 demonstrates the greatest selective effect on the mutant cells compared to the WT cells with greater than 3.5 fold relative growth inhibition of the mutant cells[3].
In Vivo	A-443654 (7.5 mg/kg/d, s.c.) inhibits tumor growth in the 3T3-Akt1 flank tumor model. A-443654 (50 mg/kg, s.c.) induces apoptosis in 3T3-Akt1 flank tumors. A-443654 (30 mg/kg, s.c.) leads to increased levels of phosphorylated Akt1 in MiaPaCa-2 tumors[1].
Cell Assay	The cells on 96-well plates are gently washed with 200 μL of PBS. Alamar Blue reagent is diluted 1:10 in normal growth media. The diluted Alamar Blue reagent (100 μL) is added to each well on the 96-well plates and incubated until the reaction is complete as per manufacturer's instructions. Analysis is done using an fmaxFluorescence Microplate Reader, set at the excitation wavelength of 544 nm and emission wavelength of 595 nm. Data are analyzed using SOFTmax PRO software provided by the manufacturer.
Animal Admin	Immunocompromised male scid mice are 6 to 8 weeks of age. The 3T3-Akt1 cell line is developed and characterized in our laboratory. The 1×106 3T3-Akt1 or 2×106 MiaPaCa-2 and PC-3 cells in 50% Matrigel are inoculated s.c. into the flank. For early treatment studies, mice are randomLy assigned to treatment groups and therapy is initiated the day after inoculation. Ten animals are assigned to each group, including controls. For established tumor studies, tumors are allowed to reach a designated size and mice are assigned to treatment groups of equal tumor size (n=10 mice per group). Tumor size is evaluated by twice weekly measurements with digital calipers. Tumor volume is estimated using the formula: V=L×W2/2. A-443654 is given s.c. in a vehicle of 0.2% HPMC. A-674563 is given orally in a vehicle of 5% dextrose.
References	[1]. Luo Y, et al. Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo. Mol Cancer Ther. 2005 Jun;4(6):977-86. [2]. Zheng J, et al. Rapamycin sensitizes Akt inhibition in malignant human breast epithelial cells. Cancer Lett. 2010 Oct 1;296(1):74-87. [3]. Gallia GL, et al. Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells. Mol Cancer Ther. 2009 Feb;8(2):386-93. [4]. Zhao Y, et al. Estrogen receptor alpha and beta regulate actin polymerization and spatial memory through an SRC-1/mTORC2-dependent pathway in the hippocampus of female mice. J Steroid Biochem Mol Biol. 2017 Nov;174:96-113.

Density	1.3±0.1 g/cm3
Boiling Point	722.0±60.0 °C at 760 mmHg
Molecular Formula	C24H23N5O
Molecular Weight	397.472
Flash Point	390.4±32.9 °C
Exact Mass	397.190247
PSA	92.61000
LogP	3.65
Vapour Pressure	0.0±2.3 mmHg at 25°C
Index of Refraction	1.722
Storage condition	-20°C

Company Profile

Our company is a high-tech enterprise specializing in chemical raw materials such as electronic materials, optoelectronic materials, semiconductor materials, UV monomers, silane catalysts, cosmetic raw materials, etc. The company integrates research and development, production, customized synthesis, and sales, and is committed to providing customers with high-quality chemical product solutions.

Our Company

Our Advantage

Rich experience

Our products have been exported to many countries, including Germany, Spain, the United Kingdom, the United States, Australia, the Middle East, Asia, and more. We have received highly positive feedback from our clients and have established long-term friendly cooperative relationships with them.

Excellent quality, purity, and competitive price

Excellent quality is one of the cornerstones of our success. We welcome ordering samples for quality testing.